Primary Immunodeficiency Disease

A two-step analytical pipeline facilitated the identification of individuals with primary immunodeficiency and accurately quantified their clinical risk, according to a study published in The Journal of Allergy & Clinical Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in September.

Children with pre-existing inborn errors of immunity may have higher mortality rates due to COVID-19 than children who do not have these errors, according to a study published in The Journal of Allergy and Clinical Immunology.

The omicron variant of the SARS-CoV-2 virus presents unique challenges for patients with immunodeficiencies and their health care providers, according to a paper published in The Journal of Allergy and Clinical Immunology: In Practice.

Ocular manifestations appeared common among patients with primary immunodeficiency diseases, suggesting a need for more integrated ocular and immunological care, according to a study.

Children with primary immunodeficiency reported fatigue that impacts their quality of life, and targeting this fatigue may improve their well-being, according to a study published in Journal of Clinical Immunology.

Patients with primary immunodeficiencies demonstrated higher COVID-19 mortality rates than the general population, according to a study conducted in Turkey and published in Journal of Clinical Immunology.

Learn about the discovery of immunodeficiencies leading to the use of pooled immunoglobulin as therapy, the struggle to use it intravenously and the eventual use in autoimmune disease.

Primary immunodeficiencies are a group of over 350 rare and chronic conditions in which genetic defects cause the immune system to function improperly.